Navigation Links
NIH panel seeks to dispel stigma associated with fecal and urinary incontinence
Date:12/12/2007

An independent panel convened this week by the NIH found that fewer than half of individuals experiencing fecal or urinary incontinencethe inability to control bowel movements or urination, respectivelyreport their symptoms to healthcare providers without being prompted. The secrecy and distress surrounding these issues erode the quality of life for millions, and hamper scientific understanding and development of prevention and treatment strategies.

Its time to remove the stigma associated with urinary and fecal incontinence, said C. Seth Landefeld, M.D., Director of the Center on Aging at the University of California San Francisco and chair of the conference panel. More than one-fourth of Americans will experience incontinence at some point in their lives. We as a society need to get over our discomfort with this subject so that incontinence sufferers receive the compassion, acceptance, and care they need, and our aging population can take steps to prevent incontinence in the future.

Removing the stigma was a key message of an NIH state-of-the-science conference, which concluded this morning. The panels full draft statement will be available later today at http://consensus.nih.gov. The statement includes recommendations for research studies to fill the major gaps in current knowledge that severely limit our ability to help people with these conditions.

The panel concluded that healthcare providers are well positioned to initiate discussions with patients about incontinence. The panel recommended further studies to determine when and how to approach patients on the topic. Although further study will be needed to find the most effective wording for asking patients about symptoms, the panel recommended that the ideal approach will address four aspects of the patients experience: frequency, volume, the degree to which symptoms bother the patient, and the patients desire for treatment.

Provider education alone will be insu
'/>"/>

Contact: Kelli Marciel
marcielk@od.nih.gov
301-496-4819
NIH/National Institutes of Health, Office of Disease Prevention
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Virginia Tech Review Panel Calls For Reform of Mental Health Treatment Law
2. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
3. Patient Safety Authority Board of Directors Names Infection Advisory Panel
4. Partners Rx Chief Pharmacy Officer, Richard Bullard on Panel Discussion at the Fall 2007 Managed Markets Summit (MMS) in Phoenix, AZ.
5. Billians HealthDATA GM Speaking on Dreamforce 07 Panel
6. FDA Panel Recommends Approval of SyntheMeds REPEL-CV(R) Adhesion Barrier for Pediatric Patients
7. Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers
8. Health Courts Critic to be Featured Speaker at Wyoming Patient Safety Panel
9. FDA Panel Mulls Ban on Kids Cold Medicines
10. FDA Panel Weighs Ban on Kids Cold Medicines
11. FDA Panel Recommends Ban on Cold Medicines for Kids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... University of Texas M. D. Anderson Cancer Cente...o eradicate breast cancer in Panama through the Pa... of the Americas today at an event with Laura Bush...Fernandez de Torrijos, the First Lady of Panama. ,... are the U.S. Department of State and Susan G. Kom...
(Date:11/21/2008)... -- U.S. News & World Report and the National ...Choice(R) HealthPlan of South Carolina in the top ...d in U.S. News & World Report,s issue this wee...he nation,s best health plans based on clinical qu...scores. NCQA and U.S. News & World Report rank...
(Date:11/21/2008)...c damage that can lead to disease , , FR...cations for treating attention-deficit hyperactivi...ked to an increased risk for developing cancer, a ...s at Duke University Medical Center and the Nation...hat reported biomarkers associated with an increas...
(Date:11/21/2008)...cond year in a row and the third time in the last ... network won more creative awards than any other a...Club Show. , , Nine McCann Healthcare Worl...rds of Excellence, including a Gold and 4 Silver. ... include Caudex Medical, echo Torre Lazur, McCann ...
Breaking Medicine News(10 mins):Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:ADHD Medications Don't Pose Cancer Risk 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 3Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 4
... of Washington shows that the work intended for gl...ate economy . The research was conducted by a UW t...hy; Amy Hagopian, professor in the School of Publi...nifer Devine, co-director of the Global Washington...
...ve C- section does not affect infants health. The ...e doctor frequently early in life according to a n... Epidemiology, Hong Kong researchers found that ba... have higher rates of hospitalization or outpatien...
...st Kevin Eubanks have won the 'World's Sexiest Veg...-year-old Underwood is not new to the title, for s...d is new to the for NBC's 'Tonight Show' band lead...votes due to his show's host Jay Leno, who urged p...
...cotine patches can double the odds of successful q...ts bupropion and nortriptyline aid long-term smoki...hibitors (e.g. fluoxetine) do not. Yet another r...oved in the UK by NICE), increased the odds of suc...
Other Medicine News:Health News:Global Health Enriching the States Economy 2Health News:C- Section Does Not Affect an Infants Health 2
(Date:11/19/2008)... , Study did not achieve statistical significan...irstCall/ -- Pharmos Corporation (Nasdaq: PARS )...l trial of its topical NanoEmulsion (NE) drug deli...hanolamine. , , The multi-center, randomize...ted the safety and efficacy of the Company,s 3% Di...
(Date:11/19/2008)..., Del., Nov. 19 Isogen, a contract...terile filling, today announced the first,phase l... was founded to,specifically address the process,...ed with the $2 billion highly-niched, low-volume c...g market segment. , Companies can invest ov...
(Date:11/18/2008)... www.christmasseals.org to learn more, make a don...WASHINGTON, Nov. 17 Mil...s month, courtesy of the American Lung Association...nnual fundraising tradition dating back to 1907 wh...erculosis. , , "Most Americans alive toda...
(Date:11/18/2008)...an Lung Association,s 2008 Faces of Influenza surv...mmunized against influenza; Mother and Gold Medali...ASHINGTON, Nov. 18 While 78 percen...za a severe and potentially life-threatening disea...ely their families will get vaccinated this season...
Breaking Medicine Technology:Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Isogen Launches Major New Facility to Address Global Biopharma Demand 2American Lung Association Celebrates 101st Annual Christmas Seals Campaign 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6Harvard Researchers Select S C BlueCross for National Honor 873 1Harvard Researchers Select S C BlueCross for National Honor 873 2Harvard Researchers Select S C BlueCross for National Honor 873 3Purdue Pharma Selects Systech to Provide Sustainable Infrastructure for Serialization 868 1Purdue Pharma Selects Systech to Provide Sustainable Infrastructure for Serialization 868 2Kiwa Bio Tech Named Recommended Brand by the China Green Food Association 463 1Kiwa Bio Tech Named Recommended Brand by the China Green Food Association 463 2SinuNase Phase 3 show almost 100 percent of chronic sinusitis cases are from fungal induced inflamma 318 1SinuNase Phase 3 show almost 100 percent of chronic sinusitis cases are from fungal induced inflamma 318 2
...March 6, 2007-Pozen Inc. (NASDAQ: POZN),today ann...325,proof-of-concept study conducted during the fo...tion of 325mg of aspirin surrounded by,a 20mg coat...n pump,inhibitor. , The PA 325, 28 day study, invo... Each subject was treated with either once a day,c...
...SINESS WIRE)--Mar 5, 2007 - Advanced Cell,Technolo...in blind,rats was noted in Scientific American,s M... section. The full text of the article,which note...cells,to turn into transplantable retinal pigment ...ortly after the company announced,its collaboratio...
Other Medicine Technology:Pozen Announces Positive Outcome for PA 325 2Pozen Announces Positive Outcome for PA 325 3Advanced Cell Technology's Ability to Rescue Vision in Blind Rats,Noted in Scientific American 2Advanced Cell Technology's Ability to Rescue Vision in Blind Rats,Noted in Scientific American 3
The Doro Halo retractor system is designed for all neurosurgical applications where retraction of the brain tissue and an armrest is required.
Molt 9, excellent for subperiosteal tunneling.
Love-Adson periosteal elevator, semi sharp, blade width 3/16" (5 mm), length 6 1/2" (165 mm).
Iowa University periosteal elevator, blade width 11/16" (17 mm), length 7 1/4" (184 mm).
Medicine Products: